← brief for 2026-11-04 · Slowing decline

Safety and Tolerability of Sodium-Glucose Cotransporter-2 Inhibitors: A State-of-the-Art Narrative Review.

Paper A Peer reviewed Meta-analysis or large trial

Key takeaways

This review looked at how safe SGLT-2 drugs are for people with kidney disease. It found that these drugs are generally well tolerated. They help protect the kidneys and the heart. This is strong evidence for their use in daily care.

Who did this work

Kunutsor SK · Seidu S

Source

Paper · PubMed, the drug frontier · 2026 Nov 3
https://pubmed.ncbi.nlm.nih.gov/42977842/